US Patent Issued to GENOME and Co. on April 14 for "Target for anti-cancer and immune-enhancing" (South Korean Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,765, issued on April 14, was assigned to GENOME AND COMPANY (Seongnam-si, South Korea).

"Target for anti-cancer and immune-enhancing" was invented by Bu-Nam Jeon (Seongnam-si, South Korea), Yun Yeon Kim (Seongnam-si, South Korea), Suro Lee (Seongnam-si, South Korea), Youn Kyung Houh (Seongnam-si, South Korea), Joo-Yeon Chung (Seongnam-si, South Korea), Areum Jeong (Seongnam-si, South Korea) and Mi Young Cha (Seongnam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a pharmaceutical composition for treating or preventing cancer, comprising inhibitors of KIRREL3, CNTN4 and/or CD351. In addition, the prese...